"Founded in 1989 under the name Tyler Hematology-Oncology, our team of highly credentialed & experienced oncologists has earned a reputation as an authority on cancer care in East Texas. Today, HOPE Cancer Center of East Texas — reflects our focus, hope, as well as our longstanding and ongoing commitment to providing the highest-quality care for people with cancer and blood disorders. To help you have hope in the fight against cancer, we bring together the complete array of modern cancer care with a powerful sense of compassion and dedication to your unique needs. From highly trained, highly skilled doctors, nurses & staff to state-of-the-art methods, unsurpassed accessibility and individualized care, we offer the top-quality care you need."

During the past decade, The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center" #1 collaborator was "Medivation, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center" are "Prostate Cancer" (2 trials), "Metastatic Non-small Cell Lung Cancer" (1 trials), "Non-small Cell Lung Cancer" (1 trials), "Recurrent Non-small Cell Lung Cancer" (1 trials) and "Relapsed/Refractory Diffuse Large B-cell Lymphoma" (1 trials). Many other conditions were trialed in "The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center" in a lesser frequency.

Most popular intervention types in "The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center" are "Drug" (4 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (2 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials), "Cisplatin (combination therapy)" (1 trials) and "Dexamethasone (combination therapy)" (1 trials). Other intervention names were less common.

The vast majority of trials in "The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center" are 2 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".